Author: René Spiegel
Publisher: John Wiley & Sons
Release Date: 2003-10-31
Describes the latest advances in psychopharmacology - one of the most rapidly developing fields in modern science. This latest edition has been updated to cover new developments in drug therapy and research including newly introduced antipsychotics, antidepressants and antidementia drugs. Sections on the treatment of depression and dementia have been revised to include new developments in treatment strategies. It will be welcomed for its essentially clinical and psychological approach to modern pharmaceuticals, their therapeutic uses and limitations, adverse reactions and future directions for research.
Author: Alan F. Schatzberg
Publisher: American Psychiatric Pub
Release Date: 2015-04-28
Standard of care in psychiatry requires that practitioners stay current on new agents, interactions, side effects, and dosing guidelines -- a daunting task for the modern clinician grappling with today's challenging medical environment. The Manual of Clinical Psychopharmacology has been the psychiatrist's trusted companion for nearly three decades, and this new, eighth edition delivers the cutting-edge information clinicians need in a down-to-earth style, facilitating the integration of biological and psychopharmacological information into practice. The book's primary purpose is to provide the reader-practitioner with a practical, usable clinical guide to the selection and prescription of appropriate drug therapies for individual patients, drawing on the authors' clinical experience as well as on the scientific literature. Students of psychiatry and psychopharmacology also will find the book useful as both text and reference. The eighth edition retains many of its most popular features, while adding others to enhance coverage and promote comprehension: Some sections dealing with less commonly used drugs (e.g., barbiturates) have been shortened or eliminated, making space for the huge number of new agents that have been approved (e.g., vortioxetine) or are likely to receive approval from the U.S. Food and Drug Administration (FDA). This makes the volume easier to use. The book has been thoroughly updated to reflect the release of DSM-5, which introduced dimensional measures of key dimensions (e.g., anxiety and depression) across diagnostic categories to better describe patients' disorders. In the chapter on diagnosis and classification, the authors review these major changes and the implications for prescribing. Features of particular utility for students include the introductory chapter on the general principles of psychopharmacological treatment and the summary medication tables, which serve as quick-reference guides on classes of psychotropics. Although largely evidence-based, the authors also draw on their extensive clinical experience in discussing various drugs' efficacy, dosing and side effects and other important factors. Two appendixes offer suggested readings for clinicians and for patients and families, as well as information on strengths and costs of antidepressant and antipsychotic drugs. There has never been a more meticulously researched and referenced guide to prescribing psychotropic medications, nor one more down-to-earth and practical. The Manual of Clinical Psychopharmacology richly deserves its reputation as a classic in the field and has earned a place on every psychiatrist's desk.
Author: John D. Preston
Publisher: New Harbinger Publications
Release Date: 2017-03-01
The Handbook of Clinical Psychopharmacology for Therapists is the go-to resource for mental health clinicians looking for clear, reliable information about the treatment of mental health issues. Organized by disorder and, within each disorder, by medication, this book is designed to familiarize clinicians and students with the basic terminology and models of pharmacokinetics. This fully revised and updated eighth edition provides essential information on new medications and treatment options and includes the latest research on side effects, contraindications, and efficacy of all major medications prescribed for mental health disorders. The book also features an important new chapter on the effects of withdrawing from psychopharmacological medications. This handbook makes it simple to: get the facts about drug interactions and side effects; find out how medications affect adults, children, and adolescents differently; learn how different cultures view medical treatment, vital information for anyone who treats clients from a variety of backgrounds; and discontinue medication safely when needed. This essential guide to psychopharmacology has been adopted as a textbook at universities nationwide and is an important resource for every therapist’s library.
Author: Alan F. Schatzberg
Publisher: American Psychiatric Pub
Release Date: 2009
Now updated to keep professionals current with the latest research and trends in the field, this edition covers both basic science and clinical practice, and draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.
Author: David Healy
Publisher: Harvard University Press
Release Date: 2009-07
David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory. But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize. Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.
Author: Ian Stolerman
Publisher: Springer Science & Business Media
Release Date: 2010-07-31
Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.
This indispensable book provides therapists and counselors with crucial knowledge about psychotropic medications: when and how to make medication referrals, how to answer patients' questions and help them handle problems that arise, and how to combine medication and psychotherapy effectively. Ideal for readers without extensive background in neurobiology, the book clearly explains how medications work in the brain and how they affect an individual's emotions, behavior, and relationships. Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. In this edition, psychopharmacology content has been fully updated.
Author: Ian M. Anderson
Publisher: CRC Press
Release Date: 2004-09-20
This book brings together leading UK psychiatrists and psychopharmacologists to review and clarify essential information about the scientific background and clinical applications of the drugs used in psychiatry. Based on the excellent Psychopharmacology Course for Psychiatrists in Training, organized twice a year by the British Association for Psychopharmacology, Fundamentals of Clinical Psychopharmacology reflects the individual lectures that make up the course, ranging from basic neuroscience to the analysis of clinical trials. The book is updated regularly, and this Second Edition includes a helpful new chapter on child and adolescent psychopharmacology.
Author: Thomas A. Ban
Publisher: Collegium Internationale Neuro-Psychopharmacologic
Release Date: 2010-04
This is volume 3 of the series The History of Psychopharmacology and the CINP, As Told in Autobiography. It covers the transformation of psychopharmacology to neuropsychopharacology in the 1980s and traces the story of the CINP during that period. This is a source book, based on a collection of memoirs of those who were there.
Author: Marc Hertzman
Publisher: John Wiley & Sons
Release Date: 2010-03-16
Although clinical trials were virtually unheard of in psychiatry for many years, they are now the gold standard for judging whether drugs are safe and useful. But should they be? What is the true status of clinical trials? Even when they ostensibly demonstrate a benefit of a certain treatment, the strict patient selection criteria, poor compliance and high drop-out rate leave the conclusions open to question. Are the new treatments really better or more cost-effective than the old? Do they have fewer side effects? In this book the authors take a critical look at recent developments and present a series of trenchant and challenging observations. Section I examines the significant changes in law and the regulatory environment that have occurred during the past ten years. Has fossilization handicapped the US Food and Drug Administration in promoting treatment advances? How can the plethora of findings be regulated? This is particularly pertinent in genomic studies and there are two chapters addressing the impact of genomics on psychiatric research. This section also addresses the role of women in drug trials – a group long excluded but now demanding a part, for without testing how can optimal treatments be devised? The next two Sections highlight clinical trials in the major areas of psychiatric pharmacological treatment, including Mood Disorders, especially Bipolar, Anxiety Disorders, and addictions. Chapters on pharmacological treatments for Eating Disorders, Attention Deficit Disorder, Autism and Asperger’s Syndrome, and Impulse Control Disorder represent the latest thinking on these subjects. The final Section contains a consummate example of out-of-the [Western]- box thinking, namely consideration of herbal medicines – used by a large number of patients, with or without medical supervision. We conclude with a close look at the problem of side effects, then selected thoughts about methodology. Clearly written, the text provides immediate access to new developments across the spectrum of drug testing. Clinical Trials in Psychopharmacology: A Better Brain is provocative reading for psychiatrists, pharmacologists and all those interested in improved drug treatments for patients with mental illness. Raises questions about the conduct of trials and the credibility of their outcomes that are relevant not just in psychiatry but all areas of medicine Discusses the ethical problems in assessing outcomes in humans, including children
Author: Stephen M. Stahl
Publisher: Cambridge University Press
Release Date: 2011-09-05
This spin-off from Stephen Stahl's new, completely revised, and fully updated fourth edition of the Prescriber's Guide covers the most important drugs in use today for treating depression. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically-informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.
Facts101 is your complete guide to Psychopharmacology , Drugs, the Brain, and Behavior. In this book, you will learn topics such as as those in your book plus much more. With key features such as key terms, people and places, Facts101 gives you all the information you need to prepare for your next exam. Our practice tests are specific to the textbook and we have designed tools to make the most of your limited study time.
Author: Joseph Wegmann
Publisher: CMI Education Institute
Release Date: 2012-01-01
Now in its second edition, Psychopharmacology: Straight Talk on Mental Health Medications is the definitive guide for healthcare professionals and anyone else seeking straightforward, concise and user-friendly information about mental disorders and the medications used to manage them. Fully revised and updated, this invaluable book has become the go-to favorite of clinicians, clients and family members intent on expanding their knowledge of Psychopharmacology Here's what you'll find: -Detailed descriptions of the disorders for which medications are most often prescribed -The very latest trends in psychiatric medication management and case study applications -Tips on medicating children, adolescents, older adults and expectant mothers -Herbals and alternative remedies: Do they work? Are they safe? -Answers to frequently asked questions -Resolving dilemmas - medication refusal, non-compliance, generic vs. brand drugs